An open label multi facilities cooperation randomized control trial to verify renoprotective effects of improvement in postprandial hyperglycemia in diabetic nephropathy.
Not Applicable
- Conditions
- Type 2 diabetic nephropathy patients.
- Registration Number
- JPRN-UMIN000003072
- Lead Sponsor
- Graduate School of Medicine, Tohoku Univwrsity
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patient who has taken SU medicine within three months recent or been taking of SU medicine in present. 2) Patient for whom insulin treatment is necessary. 3) Patient who complicates severe and actively diabetic microangiopathy (retinopathy etc...). 4) Patient who complicates severe liver disease, kidney disease and heart disease. 5) Woman who has possibility of pregnancy or pregnancy and woman while suckling. 6) Patient who has already taken glinides. 7) It is a patient of the contraindication to administer the object medicine. 8) The doctor judged the patient's participation in the study to be improper.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method